Novo Nordisk
NVO
#30
Rank
C$429.13 B
Marketcap
$97.32
Share price
-2.64%
Change (1 day)
-47.31%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): C$28.18 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are C$43.76 Billion. In 2024 the company made an earning of C$25.99 Billion, an increase over its 2023 earnings that were of C$21.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$28.18 B8.43%
2024 C$25.99 B22.75%
2023 C$21.17 B57.64%
2022 C$13.43 B5.35%
2021 C$12.75 B12.47%
2020 C$11.33 B13.07%
2019 C$10.02 B-3.35%
2018 C$10.37 B1.79%
2017 C$10.19 B4.52%
2016 C$9.75 B9.42%
2015 C$8.91 B8.24%
2014 C$8.23 B3.45%
2013 C$7.95 B19.02%
2012 C$6.68 B15.21%
2011 C$5.80 B17.71%
2010 C$4.93 B24.78%
2009 C$3.95 B10.62%
2008 C$3.57 B55.97%
2007 C$2.29 B7.07%
2006 C$2.13 B18.18%
2005 C$1.81 B11.33%
2004 C$1.62 B
2002 C$1.10 B-14.39%
2001 C$1.28 B-52.82%
2000 C$2.73 B250%
1999 C$0.78 B31.21%
1998 C$0.59 B34.31%
1997 C$0.44 B11.46%
1996 C$0.39 B9.03%
1995 C$0.36 B-3.15%
1994 C$0.37 B-0.67%
1993 C$0.37 B45.38%
1992 C$0.26 B-13.81%
1991 C$0.30 B37.12%
1990 C$0.22 B-0.79%
1989 C$0.22 B26.2%
1988 C$0.17 B24.97%
1987 C$0.14 B-0.9%
1986 C$0.14 B-7.78%
1985 C$0.15 B24.87%
1984 C$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$14.19 B-48.67%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.66 B-32.49%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.38 B-69.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$12.05 B-56.41%๐Ÿ‡ซ๐Ÿ‡ท France